Gentamicin versus ceftriaxone for the treatment of gonorrhoea (G-TOG trial): Study protocol for a randomised trial

  • Clare Brittain
  • , Margaret Childs
  • , Lelia Duley
  • , Jan Harding
  • , Trish Hepburn
  • , Garry Meakin
  • , Alan A. Montgomery
  • , Wei Tan
  • , Jonathan D.C. Ross*
  • *Corresponding author for this work

    Research output: Contribution to journalArticlepeer-review

    7 Citations (Scopus)
    Original languageEnglish
    Article number558
    JournalTrials
    Volume17
    Issue number1
    DOIs
    Publication statusPublished (VoR) - 24 Nov 2016

    Funding

    The G-TOG trial is funded by the National Institute for Health Research (NIHR) Health Technology Assessment (HTA) programme. The funder’s reference for the trial is 12/127/10. The trial is sponsored by University Hospitals Birmingham NHS Foundation Trust (UHBFT). Standard NHS Indemnity applies. C Brittain, M Childs, L Duley, T Hepburn, G Meakin, A Montgomery and W Tan are all employed by the University of Nottingham. External funding for all authors on this project is funded by the National Institute for Health Research (NIHR).

    Keywords

    • Ceftriaxone
    • Gentamicin
    • Gonorrhoea
    • Noninferiority
    • Randomised trial
    • Resistance
    • Treatment

    Fingerprint

    Dive into the research topics of 'Gentamicin versus ceftriaxone for the treatment of gonorrhoea (G-TOG trial): Study protocol for a randomised trial'. Together they form a unique fingerprint.

    Cite this